Global Animal Model Market Size, Share, Growth Analysis, By Type(Pigs, Cats), By Application(Research and Development, Production) - Industry Forecast 2023-2030

Global Animal Model Market size was valued at USD 2.26 Billion in 2022 and is poised to grow from USD 2.44 Billion in 2023 to USD 4.44 Billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The animal model market serves the purpose of furnishing researchers with dependable models that closely emulate human physiology and pathophysiology. The market's growth is primarily driven by the escalating prevalence of chronic and intricate diseases like cancer, cardiovascular disorders, and neurological conditions. It presents notable opportunities, particularly with the advancement of genetically modified animal models like transgenic mice, enabling researchers to delve into specific genes and their roles in disease progression. Furthermore, the increasing demand for personalized medicine and tailored therapies creates avenues for developing patient-derived animal models and precision medicine approaches. The global animal model market holds pivotal significance in advancing scientific knowledge and drug development. Despite encountering challenges such as ethical concerns and the emergence of alternative technologies, the market persists in offering indispensable tools for comprehending diseases and devising new treatments. The continual innovation in animal models and the surging demand for personalized medicine augur well for further growth and progress in this domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Animal Model Market Segmental Analysis

The global animal model market is segmented on the basis of type, application, and region. Based on type, the market is segmented into pigs, cats, and mice. By Application, the market is segmented into research and development, production, and quality control. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Animal Model Market

As genomics and precision medicine continue to advance, there is a growing demand for animal models that can accurately replicate individual patient characteristics and responses to treatments. Researchers and pharmaceutical companies are increasingly relying on animal models to investigate specific genetic variations and develop targeted therapies. Notably, the adoption of patient-derived xenograft (PDX) models gained momentum in 2022, where animal hosts are implanted with patient tumour samples for drug testing. These models enable the assessment of treatment efficacy tailored to individual patients, contributing to the heightened demand for animal models in personalized medicine.

The rapid progress of gene editing technologies, particularly CRISPR-Cas9, emerged as another significant driver in the 2022 animal model market. These technologies facilitate precise manipulation of genes in animal models, allowing the creation of genetically modified models that closely resemble human diseases. Researchers can introduce specific genetic mutations or modifications in animal models to explore the underlying mechanisms of diseases and develop innovative therapeutics. The widespread adoption of gene editing technologies in 2022 played a pivotal role in increasing the utilization of animal models and fostering innovation in the field.

Restraints in the Global Animal Model Market

Despite notable advancements in the field of animal models, ethical concerns and considerations for animal welfare remained significant constraints in 2022. The use of animals in research activities raises ethical questions and triggers debates regarding the humane treatment of animals. The scrutiny of animal welfare regulations and public attention has led to increased oversight of the use of animal models, especially in countries with stringent regulations pertaining to animal welfare. These ethical concerns and regulatory frameworks pose challenges to the expansion of the animal model market and incentivize the exploration of alternative technologies and models.

Another impediment observed in the market in 2022 was the high costs and complexities associated with maintaining animal facilities, procuring and breeding animals, and conducting experiments using animal models. Animal models demand dedicated facilities, specialized care, and resources, contributing to their substantial maintenance costs. Furthermore, the intricacies associated with working with animal models, such as the need for experienced personnel, adherence to regulatory requirements, and logistical challenges, amplify the overall expenses. These cost and complexity factors can restrict the accessibility and utilization of animal models, particularly for smaller research organizations operating with limited budgets.

Market Trends of the Global Animal Model Market

A notable trend observed in the 2022 animal model market was the growing emphasis on humanized and translational models. Researchers are actively working to create animal models that closely mirror human physiology, disease progression, and responses to drugs. This trend involves the integration of human cells, tissues, or genetic modifications into animal models to enhance their relevance to human diseases. For instance, the development of humanized mice with a human immune system allows for more accurate studies of immune-related diseases and testing of immunotherapies. The shift towards humanized and translational models in 2022 underscores the industry's commitment to enhancing the predictability and applicability of animal models in human disease research.